Information released by MS Research Australia (MSRA)
A review of Gilenya by the EMA has been initiated following the report of a patient in the USA who died 24 hours after taking Gilenya. The review also includes a total of 11 deaths worldwide, however the causes of these deaths were mixed and the EMA acknowledges that a relationship of these deaths to Gilenya is not established. The exact cause of death in this recent case remains uncertain.









Want to know when our upcoming MS Swimathon’s, World MS Day, the famous Brissie to the Bay bike ride or our MS Moonlight Walk are on this year?